The performance of companies tied to iconic drugs like Viagra presents a nuanced investment picture. While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key markets has introduced substantial volatility. Investors are now facing the impact of generic competi… Read More